{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"contributor": "", "original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Hedge fund manager Daniel S Loeb urges Dow Chemical to bar chief executive Andrew N Liveris from having role at company in wake of its merger with DuPont.", "type_of_material": "News", "word_count": "238", "lead_paragraph": "Daniel S. Loeb questioned the hastiness of Dow Chemical\u2019s merger with DuPont and suggested that Dow\u2019s chief, Andrew N. Liveris, may have accepted a lower price for the company to retain a role there.", "pub_date": "2015-12-14T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Hedge Fund Manager Steps Up Criticism of Dow and Its C.E.O.", "print_headline": "Hedge Fund Manager Steps Up Criticism of Dow and Its C.E.O."}, "snippet": "Daniel S. Loeb questioned the hastiness of Dow Chemical\u2019s merger with DuPont and suggested that Dow\u2019s chief, Andrew N. Liveris, may have accepted a lower price for the company to retain a role there.", "multimedia": [{"height": 126, "url": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/05/10/business/db-loeb-web1/db-loeb-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/14/business/hedge-fund-manager-steps-up-criticism-of-dow-and-its-ceo.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Dow Chemical Company", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Loeb, Daniel S", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Liveris, Andrew N", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Breen, Edward D", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Hedge Funds", "name": "subject"}], "blog": [], "_id": "566e1c9a38f0d83e10be14c4", "source": "The New York Times"}